← Eichor
Study identifier: NCT07140848 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes

Condition: PreDiabetes  ·  Sponsor: State University of New York at Buffalo

PhaseNA
Planned participants214
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.

This description comes directly from the study's public registry record.

Talk to the study team

Raphael A Fraser, PhD, MS  ·  7168295733  ·  rfraser@buffalo.edu

Jocelyn Stooks, MPH  ·  7168292364  ·  jstooks@buffalo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Population Health, Department of MedicineBuffalo, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07140848